Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Earnings Per Share Diluted of $0.15 per share for the year ending 2025.
- IRONWOOD PHARMACEUTICALS INC showed an increase of +1,400.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from IRONWOOD PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), IRONWOOD PHARMACEUTICALS INC's Earnings Per Share Diluted has grown by 108.1%.
- Historical annual values: Fiscal year 2025: $0.15 per share | Fiscal year 2024: $0.01 per share | Fiscal year 2023: $6.45 (loss) per share | Fiscal year 2022: $0.96 per share | Fiscal year 2021: $3.21 per share | Fiscal year 2020: $0.66 per share | Fiscal year 2019: $0.14 per share | Fiscal year 2018: $1.85 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: